These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19664705)

  • 41. Parenteral formulation of an antileishmanial drug candidate--tackling poor solubility, chemical instability, and polymorphism.
    Kupetz E; Preu L; Kunick C; Bunjes H
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):511-20. PubMed ID: 23454203
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Solid lipid nanoparticle (SLN) formulations as a potential tool for the reduction of cytotoxicity of saponins.
    Van de Ven H; Vermeersch M; Shunmugaperumal T; Vandervoort J; Maes L; Ludwig A
    Pharmazie; 2009 Mar; 64(3):172-6. PubMed ID: 19348339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading.
    Rosenblatt KM; Bunjes H
    Eur J Pharm Biopharm; 2017 Aug; 117():49-59. PubMed ID: 28315731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
    Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
    Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles.
    Severino P; Pinho SC; Souto EB; Santana MH
    Colloids Surf B Biointerfaces; 2011 Aug; 86(1):125-30. PubMed ID: 21543196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of nanoparticles in diluted clear solutions for Silicalite-1 zeolite synthesis using liquid 29Si NMR, SAXS and DLS.
    Follens LR; Aerts A; Haouas M; Caremans TP; Loppinet B; Goderis B; Vermant J; Taulelle F; Martens JA; Kirschhock CE
    Phys Chem Chem Phys; 2008 Sep; 10(36):5574-83. PubMed ID: 18956092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation, characterization, and anticancer effects of simvastatin-tocotrienol lipid nanoparticles.
    Ali H; Shirode AB; Sylvester PW; Nazzal S
    Int J Pharm; 2010 Apr; 389(1-2):223-31. PubMed ID: 20123009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production.
    de Waard H; Grasmeijer N; Hinrichs WL; Eissens AC; Pfaffenbach PP; Frijlink HW
    Eur J Pharm Sci; 2009 Oct; 38(3):224-9. PubMed ID: 19631270
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thermally switchable dispersions of thermochromic Ag2HgI4 nanoparticles.
    Schwiertz J; Geist A; Epple M
    Dalton Trans; 2009 Apr; (16):2921-5. PubMed ID: 19352519
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quil A-lipid powder formulations releasing ISCOMs and related colloidal structures upon hydration.
    Demana PH; Davies NM; Hook S; Rades T
    J Control Release; 2005 Mar; 103(1):45-59. PubMed ID: 15710499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An in situ real-time x-ray diffraction study of phase segregation in Au-Pt nanoparticles.
    Malis O; Radu M; Mott D; Wanjala B; Luo J; Zhong CJ
    Nanotechnology; 2009 Jun; 20(24):245708. PubMed ID: 19471088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
    Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lanthanide oleates: chelation, self-assembly, and exemplification of ordered nanostructured colloidal contrast agents for medical imaging.
    Liu G; Conn CE; Drummond CJ
    J Phys Chem B; 2009 Dec; 113(49):15949-59. PubMed ID: 19904961
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of collagen with the lipids of tendon xanthomata.
    Tall AR; Small DM; Lees RS
    J Clin Invest; 1978 Oct; 62(4):836-46. PubMed ID: 701482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid.
    Wang XQ; Huang J; Dai JD; Zhang T; Lü WL; Zhang H; Zhang X; Wang JC; Zhang Q
    Int J Pharm; 2006 Sep; 322(1-2):146-53. PubMed ID: 16787721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid nanoparticles for brain targeting III. Long-term stability and in vivo toxicity.
    Blasi P; Schoubben A; Traina G; Manfroni G; Barberini L; Alberti PF; Cirotto C; Ricci M
    Int J Pharm; 2013 Sep; 454(1):316-23. PubMed ID: 23832009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles.
    Thomas MJ; Slipper I; Walunj A; Jain A; Favretto ME; Kallinteri P; Douroumis D
    Int J Pharm; 2010 Mar; 387(1-2):272-7. PubMed ID: 20025947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isostatic ultra-high-pressure effects on supercooled melts in colloidal triglyceride dispersions.
    Blümer C; Mäder K
    Pharm Res; 2005 Oct; 22(10):1708-15. PubMed ID: 16180129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.